Company overview
Cayman Chemical is a US-based CRO and CDMO offering chemistry and biology services to pharmaceutical, biotechnology, and academic markets. They provide custom chemical synthesis, medicinal chemistry, bioanalysis, assay development, and preclinical drug discovery support including psychedelics. Additional offerings include high-purity biochemicals, assay kits, antibodies, recombinant proteins, and cGMP manufacturing across US and EU facilities.
Cayman Chemical is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services, CDMO & Manufacturing partner serving United States & Americas. Core focus areas include cayman chemical, cro services, cdmo pharma, medicinal chemistry, cgmp manufacturing, drug discovery.
Industry categories: CRO & Clinical Services, CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Cayman Chemical include Cdmo, Cro — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.caymanchem.com
- Categories
- CRO & Clinical Services, CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- cayman chemical, cro services, cdmo pharma, medicinal chemistry, cgmp manufacturing, drug discovery, bioanalysis
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What services does Cayman Chemical provide for drug discovery?
- Cayman offers preclinical drug discovery including chemical synthesis, medicinal chemistry, virtual high-throughput screening (vHTS), bioanalysis, and assay development for viability, immunology, metabolism, and GPCR signaling.
- Does Cayman Chemical have cGMP manufacturing capabilities?
- Yes, Cayman provides end-to-end cGMP manufacturing services through US- and EU-based facilities, supporting drug substance development from discovery to market for pharma and biotech clients.
- What industries and geographies does Cayman serve?
- Cayman serves global pharmaceutical, biotechnology, and academic research markets as a US-based CRO/CDMO with facilities in the US and EU.
Related editorial coverage
- AI Citation Gap in CDMO Capacity: Pharmaceutical Manufacturing Examples and Insights
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
Explore lab tools and QA/QC resources for R&D teams.
